Valproic acid as a promising agent to combat Alzheimer's disease.
Alzheimer's disease (AD) is one of the most threatening diseases to the elderly population at present. However, there is no yet efficient therapeutic method to AD. Recently, accumulating evidence indicates that valproic acid (VPA), a widely used mood stabilizer and antiepileptic drug, has neuroprotective potential relevant to AD. Moreover, VPA can induce neurogenesis of neural progenitor/stem cells both in vitro and in vivo via multiple signaling pathways. Therefore, it is suggested that VPA is a promising agent to combat AD.
Zhang
Xiu-Zhen
XZ
Shandong Provincial Research Center for Bioinformatic Engineering and Technique, Center for Advanced Study, Shandong University of Technology, Zibo 255049, PR China. sleevexz@sdut.edu.cn
Li
Xue-Juan
XJ
Zhang
Hong-Yu
HY
D000544:Alzheimer Disease / Q000188:drug therapy*; D000818:Animals; D006801:Humans; D008959:Models, Neurological; D055495:Neurogenesis / Q000187:drug effects / Q000502:physiology; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D018696:Neuroprotective Agents / Q000494:pharmacology*; D013234:Stem Cells / Q000187:drug effects / Q000502:physiology; D014635:Valproic Acid / Q000494:pharmacology*
D018696:Neuroprotective Agents; D014635:Valproic Acid